Concepedia

Mukul R. Jain

MR

Statistics

Publications

101

Citations

3.4K

H-Index

33

Active since

1993

Affiliations

Zydus Lifesciences Limited (India)(Current)

Maharaja Sayajirao University of Baroda

Mukul R. Jain is an author at Zydus Lifesciences Limited (India) specializing in pharmacology, medicinal chemistry, and medicine.

ORCID

Publications per year

1993–2024

101

Publications

101

Dual <scp>PPAR</scp>α/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental <scp>NASH</scp> models

Mukul R. Jain, Suresh Giri, Bibhuti Bhoi et al. · Liver International · 2017 · 201 citations · Full text

, , +17

Melatonin protects against lipid‐induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice

Nabanita Das, Ashok Mandala, Shamreen Naaz et al. · Journal of Pineal Research · 2017 · 155 citations

, , +17

Interactions between Neuropeptide Y and γ -Aminobutyric Acid in Stimulation of Feeding: A Morphological and Pharmacological Analysis*

Shuye Pu, Mukul R. Jain, Tamás L. Horváth et al. · Endocrinology · 1999 · 152 citations · Full text

, , +17

Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells

Jitendrakumar Patel, Jitendra Amrutiya, Priyanka Bhatt et al. · Journal of Microencapsulation · 2018 · 147 citations

, , +17

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

Divya P. Kumar, Rebecca Caffrey, Jonathon Marioneaux et al. · Scientific Reports · 2020 · 108 citations · Full text

, , +15

1–5 of 101